MGMT and central nervous system cancer: We used the collected 52 serum samples of glioma 30 days postoperatively, and 11 serum samples of recurrent gliomas detected the five‐peptide responses necessary for investigation of the changing regularity of serum MGMT autoantibodies, which are shown in Figure 3.